Helen of Troy Limited
20.07-0.08 (-0.4%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · HELE · USD
Key Stats
Market Cap
462.19MP/E (TTM)
-Basic EPS (TTM)
-28.72Dividend Yield
0%Recent Filings
8-K
CLO Judge resigns voluntarily
Helen of Troy's Chief Legal Officer Tessa N. Judge announced her voluntary resignation on October 20, 2025, effective November 28, 2025, to pursue another opportunity—no disagreements involved. She'll stay on until then for a seamless handover. The company values her leadership since joining. This shift tests transition smoothness amid ongoing operations.
8-K
2025 Stock Plan approved
Helen of Troy shareholders approved the 2025 Stock Incentive Plan at the August 20, 2025 annual meeting, reserving 1,055,000 shares plus unused shares from the prior plan for equity awards to attract and retain talent. All eight director nominees were elected with strong support, executive compensation received advisory approval, and Grant Thornton LLP was ratified as auditors. This bolsters incentive alignment amid competitive markets. Shareholder votes passed decisively.
8-K
Uzzell named Helen of Troy CEO
Helen of Troy appointed Scott Uzzell as CEO effective September 1, 2025, bringing his 30+ years of consumer products leadership from Nike, Converse, and Coca-Cola to drive innovation and growth. Uzzell receives a $1.1M base salary, 125% target bonus, $500K cash sign-on, and $3.25M in restricted stock awards vesting over three years. Brian Grass returns to CFO, ending the interim period. This leadership shift aims to restore momentum, yet hinges on execution amid market risks.
10-Q
Q1 FY2026 results
Helen of Troy's Q1 FY2026 revenue fell 10.8% y/y to $371.7M, with Home & Outdoor down 10.3% to $178.0M on softer demand in home and insulated beverageware categories, while Beauty & Wellness dropped 11.3% to $193.7M amid declines in thermometers, fans, and hair appliances, partly offset by $26.8M from the Olive & June acquisition closed in December 2024 for $224.7M cash plus up to $15.0M contingent. Gross margin slipped 1.6 points to 47.1% due to inventory obsolescence and trade-downs, yet adjusted operating income held at $16.1M (4.3% margin, down from 10.3%). A $414.4M impairment charge hammered operating loss to $407.0M and diluted EPS to -$19.65, with net loss exceeding operating by over 20% from non-deductible goodwill and a $16.5M deferred tax valuation allowance. Cash from operations rose to $58.3M, free cash flow at $44.9M (derived), bolstered by receivables inflows; debt stood at $871.0M under a $1.5B facility maturing 2029, with $605.1M revolver availability but covenants capping additional borrowing at $346.7M. Olive & June added $51.0M trade names (15-year life) and $8.0M customer relationships (8.5 years) to goodwill. Non-GAAP metrics fully reconciled in the 10-Q. Brita patent appeal looms in August 2025.
8-K
Q1 sales drop amid tariffs
Helen of Troy reported Q1 fiscal 2026 net sales of $371.7 million, down 10.8% from $416.8 million, hammered by tariffs and softer demand in thermometers, fans, and beverageware, yet buoyed by $26.8 million from the Olive & June acquisition. A massive $414.4 million non-cash impairment charge on goodwill and intangibles triggered a $19.65 GAAP loss per share, while adjusted EPS held at $0.41. Tariffs slashed revenue by 8 points. Interim CEO Brian Grass is pushing fundamentals. Q2 outlook sees sales of $408-$432 million, adjusted EPS $0.45-$0.60. Impairments expose asset vulnerabilities.
IPO
Website
Employees
Sector
Industry
CL
Colgate-Palmolive Company
75.73-1.41
CLX
Clorox Company (The)
110.67-4.55
EL
Estee Lauder Companies, Inc. (T
97.36-1.40
ELF
e.l.f. Beauty, Inc.
126.99-4.71
HNST
The Honest Company, Inc.
3.46-0.14
KVUE
Kenvue Inc.
14.31-0.20
NWL
Newell Brands Inc.
4.93-0.07
PG
Procter & Gamble Company (The)
148.77-2.60
SKIN
The Beauty Health Company
1.45-0.01
UL
Unilever PLC
60.97-0.95